Трехлетний проект был запущен в конце 2015 года и финансируется Программой здравоохранения ЕС на 2014–2020 годы.
To increase harm reduction and improve continuity of care for PWID in prison settings.
To improve early diagnosis of HIV, TB and viral hepatitis and improved linkage to care for PWID.
To improve the provision of integrated HIV, HCV and TB treatment and harm reduction for PWID
To scale up harm reduction service in the EU, based on Latvian and Lithuanian case-studies.
To update national programmes to overcome barriers to respond to HIV, TB and HCV-related needs
This three-year project was launched in late 2015 with core funding from the European Union, and is being implemented by 23 partners in 18 EU Member States.
Lux OST @LuxDocs
Wed, 06/26/2019 - 02:40
RT @HarmReductionEU: #HAREACT short video - #prison needle and syringe program (PNSP) Centre Penitentiaire Luxembourg https://t.co/Y24ui9ez…
HarmReduction.eu @HarmReductionEU
Tue, 06/25/2019 - 15:10
#HAREACT short video - #prison needle and syringe program (PNSP) Centre Penitentiaire Luxembourg… https://t.co/vkgv1kod7w
